Biocryst Pharmaceuticals (BCRX) Short term Debt (2016 - 2026)
Biocryst Pharmaceuticals' (BCRX) quarterly Short term Debt came in at $40.3 million in Q1 2026, up 17.53% YoY from $34.3 million in Q1 2025, and up 4.84% on a QoQ basis from $38.5 million in Q4 2025.
Biocryst Pharmaceuticals (BCRX) Short term Debt (2016 - 2026) Analysis & Trends
Biocryst Pharmaceuticals (BCRX) has 9 years of Short term Debt data on file, last reported at $40.3 million in Q1 2026.
- Quarterly Short term Debt rose 17.53% year-over-year to $40.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $40.3 million (up 17.53% YoY) and the FY2025 annual result came in at $38.5 million, up 17.69% from the prior year.
- Short term Debt improved to $40.3 million in Q1 2026, from $38.5 million in the prior quarter.
- In the past five years, Short term Debt ranged from a high of $40.3 million in Q1 2026 to a low of $23.6 million in Q4 2023.
- A 4-year average of $33.1 million and a median of $33.7 million in 2024 frame the typical range for Short term Debt.
- Annual changes were most pronounced in 2024 — Short term Debt soared 38.66% — and 2025, when it grew 14.2%.
- Tracing BCRX's Short term Debt over 4 years: stood at $23.6 million in 2023, then soared by 38.66% to $32.7 million in 2024, then rose by 17.69% to $38.5 million in 2025, then climbed by 4.84% to $40.3 million in 2026.
- The last three Short term Debt figures came in at $40.3 million (Q1 2026), $38.5 million (Q4 2025), and $37.7 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - |
| 10 | Biocryst Pharmaceuticals | 2.43 Bn | 2.08 Bn | 214.41 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 43.81 Mn |
| Mar 31, 2026 | 40.32 Mn |
| Dec 31, 2025 | 38.46 Mn |
| Sep 30, 2025 | 37.69 Mn |
| Jun 30, 2025 | 35.74 Mn |
| Mar 31, 2025 | 34.31 Mn |
| Dec 31, 2024 | 32.68 Mn |
| Sep 30, 2024 | 33.00 Mn |
| Jun 30, 2024 | 28.97 Mn |
| Mar 31, 2024 | 26.02 Mn |
| Dec 31, 2023 | 23.57 Mn |
| Sep 30, 2020 | 19.15 Mn |
| Mar 31, 2020 | 14.03 Mn |
| Dec 31, 2019 | 9.02 Mn |
| Sep 30, 2019 | 4.04 Mn |
| Dec 31, 2018 | 4.58 Mn |
| Sep 30, 2018 | 1.62 Mn |
| Jun 30, 2018 | 6.53 Mn |
| Mar 31, 2018 | 6.50 Mn |
| Dec 31, 2017 | 6.46 Mn |